SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : HZP-Horizon Pharmacies-NEW -- Ignore unavailable to you. Want to Upgrade?

To: Alan Cole who wrote (98)7/13/1998 10:27:00 AM
From: tom terry  Read Replies (1) | Respond to of 115
 
<"as profits are fully diluted through a comparable increase in the
number of shares provided to pharmacists that join in.">

Actually there isn't much dilution as their typical deal is 25% cash, 25% stock and 50% 5-8 year debt (seller financing). I suspect the earnings lag is due to costs of acquisition and integration which are upfront costs. There also is some dilution from their private placements to get the cash and pay for those upfront costs for the new acquisitions.



To: Alan Cole who wrote (98)7/13/1998 10:53:00 AM
From: francis terry  Read Replies (1) | Respond to of 115
 
Thank you Alan, for your quick note. After I buy I look at S/I to see if there is any one out there that knows more about stock than I do. The reason I have shares is because HZP had backed off to 11.50, went p some and if it gets back under 12 dollars it will be bought again. ----francis terry


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News